Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial

Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial

Objectives Evidence of the optimal antiplatelet therapy for elderly patients who had a stroke is limited, especially those elder than 80 years. This study aimed to explore the efficacy and safety of dual antiplatelet therapy (DAPT) in old-old patients compared with younger patients in the ticagrelor...

Full description

Saved in:
Bibliographic Details
Main Authors: Liping Liu, Yongjun Wang, Yilong Wang, Zixiao Li, Xingquan Zhao, Jing Jing, Philip M Bath, Hao Li, Xia Meng, Anxin Wang, Yong Jiang, Xinmiao Zhang, Jianhua Li, Jinxi Lin, S Claiborne Johnston, Xinsheng Han, Qin Xu, Weifeng Chen, Xuewei Xie, Xuhai Gong
Format: Article
Language:English
Published: BMJ Publishing Group
Series:Stroke and Vascular Neurology
Online Access:https://svn.bmj.com/content/early/2024/01/29/svn-2023-002450.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://svn.bmj.com/content/early/2024/01/29/svn-2023-002450.full

Similar Items